Good afternoon, ladies and gentlemen, and welcome everyone to the Maravai Life Sciences third-quarter 2024 earnings conference call. (Operator Instructions) I would now like to turn the call over to ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Maravai Lifesciences Holdings, Inc. ( (MRVI) ) has released its Q3 earnings. Here is a breakdown of the information Maravai Lifesciences ...

more potent mRNA therapeutics. Furthermore, we and our customers have found that this product is a very natural and easy substitution into existing IVT protocols and does not require extensive ...

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&DSAN DIEGO, Calif., ...

ByInvesting.com • Sep 18, 2024 Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development ...

When it comes to mRNA, optimising yield is highly important. In vitro transcription (IVT) – a method by which researchers can obtain highly pure and uniform mRNA oligonucleotides of lengths ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...